Samuel M. Freedman, M.D.
NPI 1588701379ActiveIndividual· Pediatrics, Pediatric Endocrinology· Pembroke Pines, FL
Pediatrics, Pediatric Endocrinology (M.D.) in Pembroke Pines, Florida, licensed in FL, with an NPI issued in January 2007. Novo Nordisk Inc was the largest of 4 companies reporting payments in 2025, $3,092 in all, mostly consulting fees.
Overview
| NPI | 1588701379 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Jan 31, 2007 |
| Last updated in NPPES | Apr 1, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics, Pediatric Endocrinology Primary | 2080P0205X | ME66554 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$3,092 · 24 payments from 4 companies
- 2024$5,516 · 14 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $2,843 | 9 |
| Abbvie Inc. | $192.65 | 13 |
| Neurocrine Biosciences, Inc. | $34.58 | 1 |
| Ascendis Pharma Endocrinology Inc | $21.99 | 1 |
What the 2025 payments were for
- Consulting Fee$2,790 · 3 payments
- Food and Beverage$302.06 · 21 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Pediatrics, Pediatric Endocrinology providers in Pembroke Pines
- 1245695931
- 1417312224
- 1497810949
All Pediatrics, Pediatric Endocrinology providers in Florida